Samsung Biologics has signed a contract to acquire the U.S. biopharmaceutical production facility of GlaxoSmithKline, GSK, a global pharmaceutical company headquartered in the UK. This marks the first ...

Already boasting an outsized presence in its home country of South Korea, CDMO juggernaut Samsung Biologics is making manufacturing inroads in the U.S. by way of an acquisition. Samsung Bio’s U.S.

A South Korean biomanufacturing giant is set to purchase its first drug production facility in the U.S. for a sum worthy of its tech giant parent. Samsung Biologics is the world’s largest contract ...

LONDON (Reuters) - GlaxoSmithKline is seeking binding bids by next month for a range of older drugs worth more than $3 billion, which it is likely to sell by geographical region, according to people ...

Samsung Biologics announced on the 22nd that it has acquired GlaxoSmithKline, GSK’s U.S. biopharmaceutical production facility. Analysts suggest that securing a production base in the U.S. will help ...